Preparation of Water-Soluble Compounds by Covalent Attachment of Solubilizing Moieties

The Practice of Medicinal Chemistry

Volumn , Issue , 2008, Pages 767-785

  Wermuth, Camille G ^a  

^a Prestwick Chemical Inc   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77549086254     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374194-3.00038-X     Document Type: Chapter

References (103)

1. Li, M., Wu, R.S. Tsai, J.S.C. Water-soluble derivatives of lipophilic drugs. US 7,029,918 B2, April 18, 2006.
2. Marini-Bettolo G.B. Metodos Modernos de Solubilizacion de Medicamentos Organicos. Ann. Asoc. Quim. Pharm. Urugay. 1948, 50:3-17.
3. Büchi J. Grundlagen der Arzneimittelforschung und der Synthetischen Arzneimittel 1963, Birkhaüser Verlag, Basel, pp. 220-235.
4. Stella V. Prodrugs: an overview and definition. Prodrugs as Novel Drug Delivery Systems 1975, Vol. 14:1-115. American Chemical Society, Washington, DC. T. Higuchi, V. Stella (Eds.).
5. Silverman R.B. The Organic Chemistry of Drug Design and Drug Action 1992, Academic Press, San Diego, CA, pp. 358-360.
6. Albert A. Selective Toxicity 1979, Chapman and Hall, London, pp. 403-440.
7. Hammond M.L. Recent advances in anti-infective agents. Annu. Rep. Med. Chem. 1993, Vol. 28:119-130. Academic Press, San Diego, CA. J.A. Bristol (Ed.).
8. Leeson P.D., Carling R.W., Kulagowski J.J., Mawer I.M., Moore K.W., Moseley A.M., Rowley M., Smith J.D., Stevenson G.I., Williams B.J., Baker R., Foster A.C., Kemp J.A., Tricklebank M.D. Drugs interacting with the glycine binding site. Perspectives in Medicinal Chemistry 1993, 239-257. Verlag Helvetica Chemica Acta/VHC, Basel, Weinheim. B. Testa, E. Kyburz, W. Fuhrer, R. Giger (Eds.).
9. Stilts C.E., Nelen M.I., Hilmey D.G., Davies S., Gollnick S.O., Oseroff A.R., Gibson S.L., Hilf R., Detty M.R. Water-soluble, core-modified porphyrins as novel, longer-wavelength-absorbing sensitizers for photodynamic therapy. J. Med. Chem. 2000, 43:2403-2410.
10. Bock M.G., DiPardo R.M., Mellin E.C., Newton R.C., Veber D.F., Freedman S.B. Second-generation benzodiazepine CCK-B antagonists. Development of subnanomolar analogs with selectivity and water solubility. J. Med. Chem. 1994, 37:722-724.
11. Kiesman W.F., Zhao J., Conlon P.R., Dowling J.E., Petter R.C., Lutterodt F., Jin X., Smits G., Fure M., Jayarag A. Potent and orally bioavailable 8-bicyclo[2.2.2]octylxanthines as adenosine A1 receptor antagonists. J. Med. Chem. 2006, 49:7119-7131.
12. Mesanguy, M. Procédé de préparation du flavone 5,7-dioxyacétate de sodium. French Patent 2.076.753, January 27, 1970.
13. Jackson E.L. Certain N -alkyl, N -carboxyalkyl and N -hydroxyalkyl derivatives of 4,4' -diaminodiphenyl sulfone. J. Am. Chem. Soc. 1948, 70:680-684.
14. J. Reitmann, Aliphatic amine salts of halogenated pyridones containing an acid group. US Patent 1,993,039 (March 5, 1935, to Winthrop Chemical Company, Inc., New York), 1935.
15. Bauer H. Organic compounds in chemotherapy. II. The preparation of formaldehyde sulfoxylate derivatives of sulfanilamide and of amino compounds. J. Am. Chem. Soc. 1939, 61:617-618.
16. Lin A.J., Klayman D.L., Milhous W. Antimalarial activity of new water-soluble dihydroartemisin derivatives. J. Med. Chem. 1987, 30:2147-2150.
17. Lin A.J., Sikry A.B., Kyle D.E. Antimalarial activity of new dihydroartemisin derivatives. 7. 4-(p -substituted phenyl)-4(R or S)-[10 (α or β)-dihydroartemisinoxy]butyric acids. J. Med. Chem. 1997, 40:1396-1400.
18. Lin A.J., Lee M., Klayman D.L. Antimalarial activity of new water-soluble dihydroartemisin derivatives. 2. Stereospecificity of the ether side chain. J. Med. Chem. 1989, 32:1249-1252.
19. Coker J.D., Elks J., May P.J., Nice F.A., Phillips G.H., Wall W.F. Action of some steroids on the central nervous system of the mouse. I. Synthetic methods. J. Med. Chem. 1965, 8:417-425.
20. Allais A., Rousseau G., Girault P., Mathieu J., Peterfalvi M., Branceni D., Azadian-Boulanger G., Chiffl L., Jequier R. Sur l'activité analgésique et antiinflammatoire des 4-(2' -alcoxycarbonyl phénylamino) quinoléïnes. E ur. J. Med. Chem. 1966, 12:65-70.
21. Trissel L.A. Handbook on Injectable Drugs 2007, American Society of Hospital Pharmacists, Bethesda, MD. 14th Edition.
22. Anderson B.D., Taphouse V. Initial rate studies of hydrolysis and acyl migration in methylprednisolone 21-hemisuccinate and 17- hemisuccinate. J. Pharm. Sci. 1981, 70:181-186.
23. Anderson B.D., Conradi R.A., Lambert J.W. Carboxyl group catalysis of acyl transfer reactions in corticosteroid 17- and 21-monoesters. J. Pharm. Sci. 1984, 73:604-611.
24. Sandman B., Szulczewski D., Winheuser J., Higuchi T. Rearrangement of chloramphenicol-3-monosuccinate. J. Pharm. Sci. 1970, 59:427-429.
25. Parthasarathy S. Evidence for an additional intracellular site of action of probucol in the prevention of oxidative modification of low density lipoprotein. Use of a new water-soluble probucol derivative. J. Clin. Invest. 1992, 89:1618-1621.
26. Anderson B.D., Conradi R.A., Spilman C.H., Forbes A.D. Strategies in the design of solution-stable, water-soluble prodrugs III: Influence of the pro-moiety on the bioconversion of 21-esters of corticosteroids. J. Pharm. Sci. 1985, 74:382-387.
27. Flynn G.L., Lamb D.J. Factors influencing solvolysis of corticosteroid-21-phosphate esters. J. Pharm. Sci. 1970, 59:1433-1438.
28. Melby J.C., St Cyr M. Comparative studies on absorption and metabolic disposal of water-soluble corticosteroid esters. Metabolism 1961, 10:75-82.
29. Cutolo E., Larizza A. Synthesis of 3-phosphoric ester of l -ascorbic acid. Gazz. Chim. Ital. 1961, 91:964-972.
30. Wenz, A., Göttmann, G., Koop, H. Verfahren zur Herstellung der freien Base und der Salze des Aneurin-orthophosphor-säureesters. German Patent 1 110 646 (July 13, 1961; E. Merck A.G. Darmstadt), 1961.
31. Ito, A. Hamanaka, W. Takagi, H. Wada, T. Kawada, T. Verfahren zur Herstellung eines Acylierungsproduktes von Vitamin-B 1-orthophosphorsäureester und Salzen davon. German Patent 1,130,811 (April 14, 1960 to Sankyo Kabushiki Kaisha, Tokyo), 1960.
32. Wada T., Tagaki H., Minakami H., Hamanaka W., Okamoto K., Ito A., Sahashi Y. A new thiamine derivative, S -benzoylthiamine O -monophosphate. Science 1961, 134:195-196.
33. Viscontini M., Ebnoether C., Karrer P. Einfache Synthese kristallisierter Lactoflavin-5' -phosphorsäure (Coferment des Flavinenzyms). Helv. Chim. Acta 1952, 35:457-459.
34. L.F. Fieser, Antihemorrhagic esters and methods for Producing the Same. US Patent 2,407,823 (September 17, 1946 to Research Corporation, New York), 1946.
35. Hale J.J., Mills S.G., MacCoss M., Dorn C.P., Finke P.E., Budhu R.J., Reamer R.A., Huskey S.W., Luffer-Atlas D., Dean B.J., McGowan E.M., Feeney W.P., Chiu LeeS.H., Cascieri M.A., Chicchi G.G., Kurtz M.M., Sadowski S., Ber E., Tattersall F.D., Rupniak N.M.J., Williams A.R., Rycroft W., Hargreaves R., Metzger J.M., MacIntyre D.E. Phosphorylated morpholine acetal human neurokinin-1 receptor antagonists as watersoluble prodrugs. J. Med. Chem. 2000, 43:1234-1241.
36. Chong K.-T., Ruwart M.J., Hinshaw R.R., Wilkinson K.F., Rush B.D., Yancey M.F., Strohbach J.W., Thaisrivongs S. Peptidomimetic HIV protease inhibitors: phosphate prodrugs with improved biological activities. J. Med. Chem. 1993, 36:2575-2577.
37. Fieser L.F., Fieser M. Reagents for organic synthesis 1967, John Wiley & Sons, New York, p. 198.
38. Khawaja T.A., Reese C.B. o -Phenylene phosphochloridate. A convenient phosphorylating agent. J. Am. Chem. Soc. 1966, 88:3446-3447.
39. Khawaja T.A., Reese C.B., Stewart J.C.M. A Convenient general procedure for the conversion of alcohols into their monophosphate esters. J. Chem. Soc. (C) 1970, 2090-2100.
40. Taguchi Y., Mushika Y. 2-(N, N -diethylamino)-4-nitrophenyl phosphate and its use in the selective phosphorylation of unprotected nucleosides. Tetrahedron Lett 1975, 24:1913-1916.
41. Gajda T., Zwierzak A. Phase-transfer-catalysed halogenation of di- t -butyl phosphite. preparation of di- t -butyl phosphorohalidates. Synthesis 1976, 243-244.
42. Gajda T., Zwierzak A. Di- t -butyl phosphorobromidate. A new selective phosphorylating agent containing acid-labile protecting groups. Synthesis 1977, 623-625.
43. Tener G.M. 2-Cyanoethyl phosphate and its use in the synthesis of phosphate esters. J. Am. Chem. Soc. 1961, 83:159-168.
44. Moffatt J.G. The synthesis of orotidine-5' phosphate. J. Am. Chem. Soc. 1963, 85:1118-1123.
45. Brownfield R.B., Shultz W. A direct method for the preparation of steroid-21-phosphates. Steroids 1963, 2:597-603.
46. Montgomery H.A.C., Turnbull J.H. Phosphoramidic halides; phosphorylating agents derived from morpholine. J. Chem. Soc. 1958, 1963-1967.
47. Fex H., Lundvall K.E., Olsson A. Hydrogen sulfates of natural estrogens. Acta Chem. Scand. 1968, 22:254-264.
48. Fieser L.F., Fry E.M. Water-soluble antihemorrhagic esters. J. Am. Chem. Soc. 1940, 62:228-229.
49. Stieglitz, E.; M. Matz, Verfahren zur Herstellung von Xanthinalkylschwefelsäuren oder deren Salze. German Auslegeschrift 1,090,669 (January 11, 1958 to Arzneimittelfabrik Krewel-Leuffen G.m.b. H., Eitorf/Sieg), 1958.
50. Miyabo S., Nakamura T., Kuwazima S., Kishida S. A comparison of the bioavailability and potency of dexamethazone phosphate and sulphate in man. E ur. J. Clin. Pharmacol. 1981, 20:277-282.
51. Williams D.B., Varia S.A., Stella V.J., Pitman I.H. Evaluation of the prodrug potential of the sulfate ester of acetaminophen and 3-hydroxymethyl-phenytoin. Int. J. Pharm. 1983, 14:113-120.
52. Greenberg F.H., Leung K.K., Leung M. The reaction of vitamin K 3 with sodium bisulfite. J. Chem. Ed. 1971, 48:632-634.
53. R.L. Despois, Procédé de préparation de composés aminés aromatiques solubles possédant une valeur thérapeutique, French Patent 831,366 (June 7, 1938; Rhône-Poulenc), 1938.
54. 6 -sulfoalkyl derivatives of adenosine: water-soluble and peripherally selective adenosine agonists. J. Med. Chem. 1992, 35:4143-4149.
55. Anonymous. Verfahren zur Darstellung von p-äthoxyphenylaminomethylschwefligsauren Salzen. German Patent 209,695 (8 May 1907, to Roberto Lepetit, Garessio, Italy), 1907.
56. Anonymous. Verfahren zur Darstellung von ω -methylschwefligsauren Salzen aminosubstituierter Arylpyrazolone. Ger. Patent 259,577 (October 26, 1911; to Farbwerke vorm. Meister Lucius & Brüning in Hoechst am Main), 1911.
57. Anonymous. Verfahren zur Darstellung von ω -methylschwefligsauren Salzen aminosubstituierter Arylpyrazolone. Ger. Patent 254,711 (July 21, 1911; to Farbwerke vorm. Meister Lucius & Brüning in Hoechst am Main), 1911.
58. Mutch N. A new sulphonamide (sulfonamide E.O.S.). B r. Med. J. 1941, 2:503-507.
59. Jain B.C., Iyer B.H., Guha P.C. The preparation of promin. Sci. Cult. 1946, 11:568-569. (C.A. 40, 4687 7, 1946).
60. Anonymous. Soluble diphenylsulfone. Swiss Patent 234,108 (December 1, 1944; Aktien-Gesellschaft vorm. B. Siegfried), 1949.
61. Bockmühl, M., W. Krohs, F. Racke, Windisch, K. N -methylsulphites and N -methanesulphinic acid salts of 1-aryl-2,3-dialkyl-4- alkylaminopyrazolones. US Patent 2,193,788 (March 19, 1940; Winthrop Chemical Company, Inc.), 1940.
62. Holland, D.O. Preparation of 2-alkyl-1,4-naphtaquinone-4-carboxyalkoximes. British Patent 621,934 (April 22, 1949; to Glaxo Laboratories Ltd), 1949.
63. Fischer L.J., Riegelman S. Absorption and activity of some derivatives of griseofulvin. J. Pharm. Sci. 1967, 56:469-476.
64. Tatsumi K., Ishigai M. Oxime-metabolizing activity of liver aldehyde oxidase. Arch. Biochem. Biophys. 1987, 253:413-418.
65. Negwer M. Organic-chemical drugs and their synonyms. Entry No 5760: Codoxime 1987, Vol. II. Akademie Verlag, Berlin.
66. Aichinger G., Behner O., Hoffmeister F., Schütz S. Basische tricyclische Oximinoäther und ihre pharmakologischen Eigenschaften. Arzneim.-Forsch. 1969, 19:838-845.
67. Kingsbury W.D., Boehm J.C., Jakas D.R., Holden K.G., Hecht S.M., Gallagher G., Caranfa M.J., McCabe F.L., Faucette L.F., Johnson R.K., Hertzberg R.P. Synthesis of watersoluble (aminoalkyl)camptothecin analogues: inhibition of topoisomerase I and antitumor activity. J. Med. Chem. 1991, 34:98-107.
68. Showell G.A., Bourrain S., Neduvelil J.G., Fletcher S.R., Freedman S.B., Kemp J.A., Marshall G.R., Patel S., Smith A.J., Matassa V.G. High-affinity and potent, water-soluble 5-amino-1,4-benzodiazepine CCKB/gastrin receptor antagonists containing a cationic solubilizing group. J. Med. Chem. 1994, 37:719-721.
69. Ishikawa F., Saegusa J., Inamura K., Sakuma K., Ashida S.-I. Cyclic guanidines. 17. Novel (N -substituted amino)imidazo[2,1- b ] quinazolin-2-ones: water-soluble platelet aggregation inhibitors. J. Med. Chem. 1985, 28:1387-1393.
70. Suzuki F., Shimada J., Nonaka H., Ishii A., Shiozaki S., Ichikawa S., Ono E. 7,8-Dihydro-8-ethyl-2-(3-noradamantyl)-4-propyl-1H-imidazo[2,1- i ]purin-5(4H)-one: a potent and water-soluble adenosine A1 antagonist. J. Med. Chem. 1992, 35:3572-3581.
71. 2' -activated potassium (maxi-K) channels, identification, solubility, and SAR. J. Med. Chem. 2007, 50:528-542.
72. Hassall C.H., Holmes S.W., Johnson W.H., Kröhn A., Smithen C.E., Thomas W.A. Peptido-aminobenzophenones-novel latentiated benzo-1,4-diazepines. Experientia 1977, 33:1492-1493.
73. Khandelwal Y., Rajeshwari K., Rajagopalan R., Swamy L., Dohadwalla A.N., de Souza N.J., Rupp R.H. Cardiovascular effects of new water-soluble derivatives of forskolin. J. Med. Chem. 1988, 31:1872-1879.
74. Bundgaard H., Falch E. Improved rectal and parenteral delivery of allopurinol using the prodrug approach. A rch. Pharm. Chem. Sci. Ed. 1985, 13:39-48.
75. Bundgaard H., Falch E., Jensen E. A novel solution-stable, watersoluble prodrug type for drugs containing a hydroxyl or an NH-acidic group. J. Med. Chem. 1989, 32:2503-2507.
76. Anderson B.D., Conradi R.A., Knuth K.E. Strategies in the design of solution-stable, water-soluble prodrugs I: a physical-organic approach to pro-moiety selection for 21-esters of corticosteroids. J. Pharm. Sci. 1985, 74:365-374.
77. Balkovec J.M., Black R.M., Hammond M.L., Heck J.V., Zambias R.A., Abruzzo G., Bartizal K., Kropp H., Trainor C., Schwartz R.E., McFadden D.C., Nollstadt K.H., Pittarelli L.A., Powles M.A., Schmatz D.M. Synthesis, stability, and biological evaluation of water-soluble prodrugs of a new echinocandin lipopeptide. Discovery of a potential clinical agent for the treatment of systemic candidiasis and Pneumocystis carinii pneumonia (PCP). J. Med. Chem. 1992, 35:194-198.
78. Klosa J. Beitrag zur Reaktionsfähigheit der 7-Stellung des Theophyllins. 2.Mitt. Über Synthesen in der Theophyllinreihe. Arch. Pharm. 1955, 288:301-303.
79. Gottstein W.J., Minor W.F., Cheney L.C. Carboxamido derivatives of tetracyclines. J. Am Chem. Soc. 1959, 81:1198-1201.
80. Sanchez J.P., Domagala J.M., Heifetz C.L., Priebe S.R., Sesnie J.A., Trehan A.K. Quinolone antibacterial agents. Synthesis and structure-activity relationships of a series of amino acid prodrugs of racemic and chiral 7-(3-amino-1-pyrrolidinyl)quinolones. Highly soluble quinolone prodrugs with in vivo pseudomonas activity. J. Med. Chem. 1992, 35:1764-1773.
81. Sawada S., Yaegashi T., Furuta T., Yokokura T., Miyasaka T. Chemical modification of an antitumor alkaloid, 20(S)-camptothecin: E-lactone ring modified water-soluble derivatives of 7-ethylcamptothecin. Chem. Pharm. Bull. 1993, 41:310-313.
82. Boyd S.A., Fung A.K.L., Baker W.R., Mantei R.A., Armiger Y.-L., Stein H.H., Cohen J., Egan D.A., Barlow J.L., Klinghofer V., Verburg K.M., Martin D.L., Young G.A., Polakowski J.S., Hoffman D.J., Garren K.W., Perun T.J., Kleinert H.D. C-Terminal modifications of nonpeptide renin inhibitors: improved oral bioavailability via modification of physicochemical properties. J. Med. Chem. 1992, 35:1735-1746.
83. Morch P. Glykresin. Arch. Pharm. Chem. 1947, 54:327-332.
84. Roth H.J. Zur Darstellung von β -Oxyalkyl-dimethyl-purinen; Umsetzung von Theophyllin und Theobromin mit 1,2-Epoxyden. Arch. Pharm. 1959, 292:234-238.
85. P.J. Courbat, Qercetin and Quercetin Gycoside. US Patent3,420,815 (January 7, 1969; to Zyma S.A.), 1969.
86. Mouzin G., Cousse H., Autin J.M. A new, convenient synthesis of glafenine and floctafenine. Synthesis 1980, 12:54-55.
87. Boltze K.H., Kreisfeld H. Zur Chemie von Etofenamat, einem Antiphlogisticum aus der Klasse der N -Arylanthranylsäurederivate. Arzneimit.-Forsch.-Drug Des. 1977, 27:1300-1312.
88. M. Matter, Polyethoxy ethers of isocyclic organic carboxylic acids. US Patent 2,714,608 (August 2, 1955; to Ciba Pharmaceutical Products, Inc., Summit, N.J.), 1955.
89. T. Nagakawa, T. Muneyuki, Y. Mori, Water solubilization by means of polyethylene glycol derivatives. Japan Patent7455 CA (1961) 55, 5879b, 1961.
90. T. Nagakawa, T. Muneyuki, Y. Mori, Water solubilization of drugs. Japan Patent 17006, November 17, 1960.
91. Weiner B.-Z., Zilkha A. Polyethylene glycol derivatives of procaine. J. Med. Chem. 1973, 16:573-574.
92. H. Morren, New derivatives of N -mono-benzhydril-piperazine and process for the preparation thereof. British Patent 817,231 (July 29, 1959), 1959.
93. Gouin d'Ambrières, S., A. Lutz, J.C. Gasc, Novel erythromycin a derivatives. US Patent 4,349,545 (September 14, 1982; to Roussel-UCLAF), 1982.
94. Miescher K., Fischer W.H., Meystre C. 6. Über Steroide. (33. Mitteilung). Über Glukoside des Desoxy-corticosterons. Helv. Chim. Acta 1942, 25:40-42.
95. Miescher K., Meystre C. 26. Über Steroide. 34. Mitteilung. Über Sacharide des Desoxy-corticosterons II. H elv. Chim. Acta 1943, 26:224-233.
96. Meystre C., Miescher K. Über Steroide. (35. Mitteilung). Zur Darstellung von Saccharidderivaten der Steroide. H elv. Chim. Acta 1944, 27:231-236.
97. T. Higashiyama, I. Sakata, Mentholglykoside, Verfahren zur ihrer Herstellung, ihre Verwendung zur Entwicklung des Pfefferminzgeschmack sowie diese Verbindungen enthaltende Arzneimittel. German Offen. 2.242.237 (August 28, 1972; to Toyo Hakka Kogyo Kabushiki Kaishy), 1972.
98. C. Chavis, Imbach, J.-L. Sur une méthode de pharmacomodulation: l'utilisation du vecteur sucre. in: Actualités de Chimie Thérapeutique (Combet-C. Farnoux (Ed.), Vol. 5, Société de Chimie Thérapeutique, Châtenay-Malabry, 1977, pp. 3-28.
99. Bognar R., Nanasi P. N -substituted glycosylamines derived from sulphanilamide and p -aminosalicylic acid. J. Chem. Soc. 1953, 1703-1708.
100. Sah P. d -Glucuronolactone isonicotinyl hydrazone. J. Am. Chem. Soc. 1953, 75:2512-2513.
101. A. Demetrio, F. Ganzina, M. Magi, E. Serino, E. Paroli, F. Samueli, Antiinflammatory di-(+6/11/2008)glucosamide of 1-(4-chlorobenzoyl)-2-methyl-5-methoxyindole-3-acetic acid. German Patent 2,223,051 (December 13, 1973; to SIR Lab. Chimico Biologici SpA); CA 80, 83529e, 1974.
102. T.H. O. Almen, J. Haavaldsen, Nordal, V. N -(2,4,6-triiodobenzoyl)-sugar amines. US Patent 3,701,771 (October 31,1972; to Nyegaard & Co, A/S), 1972.
103. Hilae S.K., Dauth G.W., Hess K.H., Gilman S. Development and evaluation of a new water-soluble iodinated myelographic contrast medium with markedly reduced convulsive effects. Radiology 1978, 126:417-422.